Alpha Teknova Files 2024 10-K, Details Credit Agreement
Ticker: TKNO · Form: 10-K · Filed: Mar 7, 2025 · CIK: 1850902
| Field | Detail |
|---|---|
| Company | Alpha Teknova, Inc. (TKNO) |
| Form Type | 10-K |
| Filed Date | Mar 7, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, financials, credit-agreement, options
TL;DR
Alpha Teknova's 2024 10-K is out. Key updates include credit agreement changes and option repricing.
AI Summary
Alpha Teknova, Inc. filed its 2024 10-K on March 8, 2025, detailing its fiscal year ending December 31, 2024. The company, operating in the in vitro & in vivo diagnostic substances sector, is incorporated in Delaware and headquartered in Hollister, California. Key financial events and agreements mentioned include an amended credit agreement and a repricing of outstanding options on March 14, 2024.
Why It Matters
This filing provides investors with a comprehensive overview of Alpha Teknova's financial performance, strategic decisions, and risk factors for the fiscal year 2024, impacting investment decisions.
Risk Assessment
Risk Level: medium — The filing mentions customer concentration risk and potential impacts from credit agreements, indicating potential financial vulnerabilities.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2025-03-07 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- Alpha Teknova, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-03-07 (date) — Filing date
- 2835 (industry_code) — Standard Industrial Classification for In Vitro & In Vivo Diagnostic Substances
- DE (state) — State of incorporation
- CA (state) — State of business address
- 2024-03-14 (date) — Date of option repricing
- Amended Credit Agreement (legal_document) — Significant financial agreement mentioned
FAQ
What is the primary business of Alpha Teknova, Inc.?
Alpha Teknova, Inc. operates in the 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES' sector, as indicated by its SIC code 2835.
When did Alpha Teknova's fiscal year end for this filing?
The conformed period of report for this 10-K filing is 2024-12-31, meaning the fiscal year ended on December 31, 2024.
What significant financial event occurred on March 14, 2024?
On March 14, 2024, Alpha Teknova engaged in the 'RepricingOfOutstandingAndUnexercisedOptionsMember'.
What is Alpha Teknova's state of incorporation?
Alpha Teknova, Inc. is incorporated in Delaware (DE).
Does the filing indicate any customer concentration risks?
Yes, the filing mentions 'us-gaap:CustomerConcentrationRiskMember' in relation to 'tkno:DistributorCustomerAMember' and 'tkno:InventoryPurchasesMember', as well as 'us-gaap:AccountsPayableMember'.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 7, 2025 regarding Alpha Teknova, Inc. (TKNO).